Skip to content
healthcare.dev

Aesculus

NDC 60986-1027, Potentilla Anserina, Aesculus Hippocastanum, Ustilago Maidis, Secale Cornutum, Ruta Graveolens, liquid, from Marco Pharma International LLC..

Product NDC
60986-1027
Status
Listed
Labeler
Marco Pharma International LLC.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60986-1027 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ARGENTINA ANSERINA FLOWERING TOP1 [hp_X]/mL
  • HORSE CHESTNUT1 [hp_X]/mL
  • USTILAGO MAYDIS5 [hp_X]/mL
  • CLAVICEPS PURPUREA SCLEROTIUM4 [hp_X]/mL
  • RUTA GRAVEOLENS WHOLE3 [hp_X]/mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]

Package NDCNDC-11Package
60986-1027-36098610270350 mL in 1 BOTTLE, GLASS (60986-1027-3)
60986-1027-460986102704100 mL in 1 BOTTLE, GLASS (60986-1027-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 60986-1027 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60986-1027 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60986-1027. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.